JACQUES JM
VAN DONGEN
Investigador
Hospital of the University of Pennsylvania
Filadelfia, Estados UnidosPublicaciones en colaboración con investigadores/as de Hospital of the University of Pennsylvania (2)
2005
-
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence
Cancer, Vol. 104, Núm. 7, pp. 1442-1452
2002
-
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
Leukemia, Vol. 16, Núm. 9, pp. 1627-1636